NON-CUTANEOUS MELANOMA
Clinical trials for NON-CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new NON-CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for NON-CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial tests new drug to stop deadly skin Cancer's return
Disease control OngoingThis large study is testing if a newer immunotherapy drug, pembrolizumab, is better at preventing melanoma from coming back after surgery than the current standard treatments. It involves over 1,300 patients with stage III or IV melanoma who have had their cancer surgically remov…
Matched conditions: NON-CUTANEOUS MELANOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
First human test: using Patients' own immune cells to fight advanced skin cancer
Disease control OngoingThis early-stage study is testing a personalized treatment called TBio-4101 for people with advanced melanoma that hasn't responded to standard therapies. Doctors take immune cells from a patient's tumor, grow them in large numbers in a lab, and then infuse them back into the pat…
Matched conditions: NON-CUTANEOUS MELANOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC